Teng Gao

Teng Gao

Auto-generated profile, based on publicly available information

Teng Gao

Department of Biomedical Informatics, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2018 in Biofabrication
Verified
Journal Article
Closed access
PDF file
TGTeng Gao
Teng Gao
Gregory GillispieGregory Gillispie
Gregory Gillispie
JCJoshua S Copus
Joshua S Copus
PKPR Anil Kumar
PR Anil Kumar
YSYoung-Joon Seol
Young-Joon Seol
SLSang Jin Jin Lee
Sang Jin Jin Lee
Three-dimensional bioprinting has emerged as a promising technique in tissue engineering applications through the precise deposition of cells and biomaterials in a layer-by-layer fashion. However, the limited availability of hydrogel bioinks is frequently cited as a major issue for the advancement of cell-based extrusion bioprinting technologies. It is well known that highly viscous materials maintain their structure better, but also have decreased cell viability due to the higher forces which are required for extrusion. However, little is known about the effect of the two distinct components of dynamic modulus of viscoelastic materials, storage modulus ( G ′) and loss modulus ( G ″), on the printability of hydrogel-based bioinks. Additionally, ‘printability’ has been poorly defined in the literature, mostly consisting of gross qualitative measures which do not allow for direct comparison of bioinks. This study developed a framework for evaluating printability and investigated the effect of dynamic modulus, including storage modulus ( G ′), loss modulus ( G ″), and loss tangent ( G ″/ G ′) on the printing outcome. Gelatin and alginate as model hydrogels were mixed at various concentrations to obtain hydrogel formulations with a wide range of storage and loss moduli. These formulations were then evaluated for the quantitatively defined values of extrudability, extrusion uniformity, and structural integrity. For extrudability, increasing either the loss or storage modulus increased the pressure required to extrude the bioink. A mathematical model relating the G ′ and G ″ to the required extrusion pressure was derived based on the data. A lower loss tangent was correlated with increased structural integrity while a higher loss tangent correlated with increased extrusion uniformity. Gelatin–alginate composite hydrogels with a loss tangent in the range of 0.25–0.45 exhibited an excellent compromise between structural integrity and extrusion uniformity. In addition to the characterization of a common bioink, the methodology introduced in this paper could also be used to evaluate the printability of other bioinks in the future.

26 September 2022 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
TGTeng Gao
Teng Gao
RSRuslan Soldatov
Ruslan Soldatov
HSHirak Sarkar
Hirak Sarkar
AKAdam Kurkiewicz
Adam Kurkiewicz
EBEvan Biederstedt
Evan Biederstedt
PKPeter V. Kharchenko
Peter V. Kharchenko

13 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
KBKelly L. Bolton
Kelly L. Bolton
YKYoungil Koh
Youngil Koh
MFMichael B. Foote
Michael B. Foote
HIHogune Im
Hogune Im
JJJustin Jee
Justin Jee
AZAhmet Zehir
Ahmet Zehir
Acquired somatic mutations in hematopoietic stem and progenitor cells (clonal hematopoiesis or CH) are associated with advanced age, increased risk of cardiovascular and malignant diseases, and decreased overall survival. These adverse sequelae may be mediated by altered inflammatory profiles observed in patients with CH. A pro-inflammatory immunologic profile is also associated with worse outcomes of certain infections, including SARS-CoV-2 and its associated disease Covid-19. Whether CH predisposes to severe Covid-19 or other infections is unknown. Among 525 individuals with Covid-19 from Memorial Sloan Kettering (MSK) and the Korean Clonal Hematopoiesis (KoCH) consortia, we show that CH is associated with severe Covid-19 outcomes (OR = 1.85, 95%=1.15–2.99, p = 0.01), in particular CH characterized by non-cancer driver mutations (OR = 2.01, 95% CI = 1.15–3.50, p = 0.01). We further explore the relationship between CH and risk of other infections in 14,211 solid tumor patients at MSK. CH is significantly associated with risk of Clostridium Difficile (HR = 2.01, 95% CI: 1.22–3.30, p = 6×10−3) and Streptococcus/Enterococcus infections (HR = 1.56, 95% CI = 1.15–2.13, p = 5×10−3). These findings suggest a relationship between CH and risk of severe infections that warrants further investigation.

12 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
TGTeng Gao
Teng Gao
RPRyan Ptashkin
Ryan Ptashkin
KBKelly L. Bolton
Kelly L. Bolton
MSMaria Sirenko
Maria Sirenko
CFChristopher Fong
Christopher Fong
EPElli Papaemmanuil
Elli Papaemmanuil
Stably acquired mutations in hematopoietic cells represent substrates of selection that may lead to clonal hematopoiesis (CH), a common state in cancer patients that is associated with a heightened risk of leukemia development. Owing to technical and sample size limitations, most CH studies have characterized gene mutations or mosaic chromosomal alterations (mCAs) individually. Here we leverage peripheral blood sequencing data from 32,442 cancer patients to jointly characterize gene mutations (n = 14,789) and mCAs (n = 383) in CH. Recurrent composite genotypes resembling known genetic interactions in leukemia genomes underlie 23% of all detected autosomal alterations, indicating that these selection mechanisms are operative early in clonal evolution. CH with composite genotypes defines a patient group at high risk of leukemia progression (3-year cumulative incidence 14.6%, CI: 7–22%). Multivariable analysis identifies mCA as an independent risk factor for leukemia development (HR = 14, 95% CI: 6–33, P < 0.001). Our results suggest that mCA should be considered in conjunction with gene mutations in the surveillance of patients at risk of hematologic neoplasms.

20 January 2026 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JMJonathan Mitchel
Jonathan Mitchel
TGTeng Gao
Teng Gao
VPViktor Petukhov
Viktor Petukhov
ECEli Cole
Eli Cole
PKPeter V. Kharchenko
Peter V. Kharchenko

15 July 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JLJie Liu
Jie Liu
DTDuc Tran
Duc Tran
LXLiying Xue
Liying Xue
BWBrian J. Wiley
Brian J. Wiley
CVCaitlyn Vlasschaert
Caitlyn Vlasschaert
KBKelly L. Bolton
Kelly L. Bolton
With age, clonal expansions occur pervasively across normal tissues yet only in rare instances lead to cancer, despite being driven by well-established cancer drivers. Characterization of the factors that influence clonal progression is needed to inform interventional approaches. Germline genetic variation influences cancer risk and shapes tumor mutational profile, but its influence on the mutational landscape of normal tissues is not well known. Here we studied the impact of germline genetic variation on clonal hematopoiesis (CH) in 731,835 individuals. We identified 22 new CH-predisposition genes, most of which predispose to CH driven by specific mutational events. CH-predisposition genes contribute to unique somatic landscapes, reflecting the influence of germline genetic backdrop on gene-specific CH fitness. Correspondingly, somatic–germline interactions influence the risk of CH progression to hematologic malignancies. These results demonstrate that germline genetic variation influences somatic evolution in the blood, findings that likely extend to other tissues.